Mr. Pascoe joins Apricus Bio from Somaxon Pharmaceuticals, Inc., where he was Chief Executive Officer since August 2008. At Somaxon, Mr. Pascoe was responsible for the FDA approval and successful commercialization of the Company's lead drug Silenor® and its recent sale to Pernix Therapeutics.
Successful???? I lost my saving with Somaxon. Pascoe should have cancer busting out of his gut.
"Richard has a proven record of setting and executing on value-building corporate strategy."
The PR person at Apricus who wrote the above sentence should have his lying tongue scalded with a hot knife. Oh where is Sharia Law when you need it?
You found out the hard way Dc. Pascoes second option was the gig stifel had lined up for him at the south Boston McDonald's where they were working so hard on that big buyout you were hoping for. I hope you didn't roll your loses into ptx chasing another winner! Don't say I didn't tell you so